Interest Expense in USD of GUIDED THERAPEUTICS INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
GUIDED THERAPEUTICS INC quarterly/annual Interest Expense history and change rate from Q2 2010 to Q3 2025.
  • GUIDED THERAPEUTICS INC Interest Expense for the quarter ending 30 Sep 2025 was $129K, a 19.4% increase year-over-year.
  • GUIDED THERAPEUTICS INC Interest Expense for the twelve months ending 30 Sep 2025 was $567K, a 77.7% increase year-over-year.
  • GUIDED THERAPEUTICS INC annual Interest Expense for 2024 was $381K, a 37.1% increase from 2023.
  • GUIDED THERAPEUTICS INC annual Interest Expense for 2023 was $278K, a 52.2% decline from 2022.
  • GUIDED THERAPEUTICS INC annual Interest Expense for 2022 was $582K, a 49.4% decline from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

GUIDED THERAPEUTICS INC Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $567K $129K +$21K +19.4% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $546K $157K +$82K +109% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $464K $147K +$83K +130% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $381K $134K +$62K +86.1% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 $319K $108K +$37K +52.1% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 $282K $75K +$6K +8.7% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $276K $64K -$2K -3.03% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $278K $72K +$2K +2.86% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $276K $71K -$84K -54.2% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $360K $69K -$187K -73% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 $547K $66K -$35K -34.7% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 $582K $70K -$30K -30% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $612K $155K -$439K -73.9% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 $1.05M $256K -$59K -18.7% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $1.11M $101K -$40K -28.4% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $1.15M $100K -$44K -30.6% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 $1.19M $594K +$277K +87.4% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $917K $315K +$7K +2.27% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $910K $141K -$146K -50.9% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $1.06M $144K -$257K -64.1% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $1.31M $317K -$59K -15.7% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $1.37M $308K +$44K +16.7% 01 Apr 2020 30 Jun 2020 10-Q 18 Aug 2021
Q1 2020 $1.33M $287K -$84K -22.6% 01 Jan 2020 31 Mar 2020 10-Q/A 18 Aug 2021
Q4 2019 $1.41M $401K -$583K -59.2% 01 Oct 2019 31 Dec 2019 10-K 07 Apr 2021
Q3 2019 $2M $376K +$137K +57.3% 01 Jul 2019 30 Sep 2019 10-Q/A 05 Nov 2020
Q2 2019 $1.86M $264K -$32K -10.8% 01 Apr 2019 30 Jun 2019 10-Q 20 Aug 2020
Q1 2019 $1.89M $371K +$127K +52% 01 Jan 2019 31 Mar 2019 10-Q 07 Jul 2020
Q4 2018 $1.76M $984K +$694K +239% 01 Oct 2018 31 Dec 2018 10-K 20 Apr 2020
Q3 2018 $1.07M $239K -$29K -10.8% 01 Jul 2018 30 Sep 2018 10-Q 09 Mar 2020
Q2 2018 $1.1M $296K -$29K -8.92% 01 Apr 2018 30 Jun 2018 10-Q 11 Feb 2020
Q1 2018 $1.13M $244K +$21K +9.42% 01 Jan 2018 31 Mar 2018 10-Q 11 Jul 2019
Q4 2017 $1.11M $290K -$8K -2.69% 01 Oct 2017 31 Dec 2017 10-K 08 May 2019
Q3 2017 $1.11M $268K +$42K +18.6% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $1.07M $325K -$888K -73.2% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 $1.96M $223K +$65K +41.1% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018
Q4 2016 $1.9M $298K +$200K +204% 01 Oct 2016 31 Dec 2016 10-K/A 20 Apr 2018
Q3 2016 $1.7M $226K -$178K -44.1% 01 Jul 2016 30 Sep 2016 10-Q 20 Nov 2017
Q2 2016 $1.87M $1.21M +$890K +276% 01 Apr 2016 30 Jun 2016 10-Q 18 Aug 2017
Q1 2016 $983K $158K -$334K -67.9% 01 Jan 2016 31 Mar 2016 10-Q 22 May 2017
Q4 2015 $1.32M $98K -$436K -81.6% 01 Oct 2015 31 Dec 2015 10-K 22 Mar 2017
Q3 2015 $1.75M $404K +$33K +8.9% 01 Jul 2015 30 Sep 2015 10-Q 05 Dec 2016
Q2 2015 $1.72M $323K +$276K +587% 01 Apr 2015 30 Jun 2015 10-Q 17 Aug 2016
Q1 2015 $1.44M $492K +$465K +1722% 01 Jan 2015 31 Mar 2015 10-Q 19 May 2016
Q4 2014 $979K $534K +$524K +5240% 01 Oct 2014 31 Dec 2014 10-K 15 Mar 2016
Q3 2014 $455K $371K +$360K +3273% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 $95K $47K +$38K +422% 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015
Q1 2014 $57K $27K +$12K +80% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q4 2013 $45K $10K -$10K -50% 01 Oct 2013 31 Dec 2013 10-K 25 Mar 2015
Q3 2013 $55K $11K -$5K -31.3% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014
Q2 2013 $60K $9K -$10K -52.6% 01 Apr 2013 30 Jun 2013 10-Q 13 Aug 2014
Q1 2013 $70K $15K -$2K -11.8% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 $72K $20K +$2K +11.1% 01 Oct 2012 31 Dec 2012 10-K 26 Mar 2014
Q3 2012 $70K $16K -$5K -23.8% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013
Q2 2012 $75K $19K +$1K +5.56% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 $74K $17K -$6K -26.1% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013
Q4 2011 $80K $18K 01 Oct 2011 31 Dec 2011 10-K 27 Mar 2013
Q3 2011 $21K 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012
Q2 2011 $18K +$46K 01 Apr 2011 30 Jun 2011 10-Q/A 24 Aug 2012
Q1 2011 $23K 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012
Q2 2010 -$28K 01 Apr 2010 30 Jun 2010 10-Q 14 Nov 2011

GUIDED THERAPEUTICS INC Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $381K +$103K +37.1% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $278K -$304K -52.2% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 $582K -$568K -49.4% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $1.15M +$94K +8.9% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $1.06M -$356K -25.2% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 $1.41M -$351K -19.9% 01 Jan 2019 31 Dec 2019 10-K 07 Apr 2021
2018 $1.76M +$657K +59.4% 01 Jan 2018 31 Dec 2018 10-K 20 Apr 2020
2017 $1.11M -$789K -41.6% 01 Jan 2017 31 Dec 2017 10-K 08 May 2019
2016 $1.9M +$578K +43.9% 01 Jan 2016 31 Dec 2016 10-K/A 20 Apr 2018
2015 $1.32M +$338K +34.5% 01 Jan 2015 31 Dec 2015 10-K 22 Mar 2017
2014 $979K +$934K +2076% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2016
2013 $45K -$27K -37.5% 01 Jan 2013 31 Dec 2013 10-K 25 Mar 2015
2012 $72K -$8K -10% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2014
2011 $80K -$1.15M -93.5% 01 Jan 2011 31 Dec 2011 10-K 27 Mar 2013
2010 $1.23M 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.